We are delighted to reach this milestone with Arbiom, as this achievement is essential in scaling up the company’s industrial biotechnology to commercial production.
The Bio Base Europe Pilot Plant looks forward to working with Arbiom to build on this successful demonstration as the company continues to scale-up its process technology.
SMARTBOX will develop an advanced computational engineering platform specifically for oxidative enzymes. Relying on this platform, SMARTBOX will develop the one-enzyme conversion of HMF into FDCA and intermediates, and the one-enzyme conversion of lignin monomers into a potential biobased building block for polycarbonates and vanillin.
The AFTERLIFE project proposes a flexible, cost- and resource-efficient process for recovering and valorising the relevant fractions from wastewater.
The grand challenge of the SYLFEED demonstration project is to scale-up and validate the bio-refinery process that converts lignocellulose into SCP suitable to formulate fish feed.
Opbouw van nieuwe demonstratie apparatuur – Building new demonstration equipment
Sugar beet pulp (SBP) accounts for approx. 13 million tonnes in Europe and is a major residual stream from the sugar beet industry, which is currently valorised as low value feed and/or green gas. In order to increase the value of its side streams, PULP2VALUE developed multiple extraction techniques to isolate more valuable products from this large fraction of sugar beet pulp.
2G BIOPIC proposes a new approach: bioethanol production from lignocellulosic biomass. This technology is based on a highly effective clean deconstruction of lignocellulosic biomass, an advanced organosolv technology, for which several patents have been submitted in the past decade by CIMV. An original and efficient biomass refining technology allows optimal extraction of the three main biomass components and downstream biotechnological transformation.
Europe, Flanders and the Province of East-Flanders invest €1,27 million in new equipment for Bio Base Europe Pilot Plant. These funds were used to purchase and install three new bioreactors with auxiliary equipment and software: two with a volume of 1.500L and one with a volume of 15.000L. This investment enables BBEPP to provide services to even more companies and it will have a larger capacity for producing industrially relevant quantities of innovative biobased products. This is an important tool for companies that wish to test the production of larger batches to prepare market introduction before investing in a full scale production line. Companies collaborating with BBEPP for process validation and scale-up can substantially reduce costs, risks and development time and will reinforce the chance to successful market entry.